Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,209,114
-
Share change
-
-1,609,160
-
Total reported value
-
$17,917,491
-
Price per share
-
$0.84
-
Number of holders
-
47
-
Value change
-
-$1,446,614
-
Number of buys
-
8
-
Number of sells
-
34
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q3 2019
As of 30 Sep 2019,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,209,114 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, GREAT POINT PARTNERS LLC, BlackRock Inc., VANGUARD GROUP INC, MACQUARIE GROUP LTD, HarbourVest Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.